Serial #79199896
LIVE

Serial Number

79199896

Owner

Albumedix Ltd

Attorney

Karen Lim

Filing Date

Aug 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79199896 Trademark

Serial Number: 79199896 • Registration: 5471871

Serial #79199896 is a trademark filed by Albumedix Ltd on August 15, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Albumedix Ltd (16 trademarks)

HQ, Mabel Street

Entity Type: 99

ALBUMEDIX A/S (13 trademarks)

LOTTENBORGVEJ 26
LYNGBY , DK

Entity Type: 11

Trademark Details

Filing Date

August 15, 2016

Registration Date

May 22, 2018

Published for Opposition

March 6, 2018

Goods & Services

Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; recombinant human albumin-based preparations for pharmaceutical and medical purposes sold as an integral component of a vaccine and pharmaceutical preparations for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use and medical use; diagnostic agents for imaging for medical purposes

Chemicals for the manufacture of pharmaceutical products; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents

Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 18, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 18, 2024 C75A
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Dec 18, 2024 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 26, 2024 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 23, 2021 ADCH
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2020 REAP
CHANGE OF OWNER RECEIVED FROM IB
Oct 11, 2018 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 6, 2018 FIMP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 6, 2018 LIMN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 6, 2018 CORN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 6, 2018 LIMN
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 22, 2018 FICR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 10, 2018 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Aug 10, 2018 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Jul 27, 2018 LIMG
REGISTERED-PRINCIPAL REGISTER
May 22, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Mar 9, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 22, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 22, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 22, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 22, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 21, 2017 GNFN
FINAL REFUSAL E-MAILED
Jul 21, 2017 GNFR
FINAL REFUSAL WRITTEN
Jul 21, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2017 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 17, 2017 NREP
REFUSAL PROCESSED BY IB
Feb 3, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 14, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 11, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 10, 2017 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2017 REPR